By using DiabetesTimes.co.uk, you agree to our terms and use of cookies to enhance your experience.

Sanofi launches highest unit capacity basal insulin pen for adults with diabetes

By Editor
3rd June 2019
Pharmaceutical

Sanofi has launched a new long-acting insulin glargine injection pen recommended for adults with type 1 or type 2 diabetes mellitus requiring at least 20 units of basal insulin per day.

The company announced the launch of Toujeo® (insulin glargine 300 units/mL) DoubleStar on Monday, June 3.

Delivering 2-160 units in a single injection, DoubleStar has the highest unit capacity of any basal insulin pen on the market, Sanofi said. For people requiring more than 20 units of insulin, DoubleStar will last longer compared to any other basal insulin pen, the company added.

Dr Mohamed Elnaggar, Associate Specialist of Diabetes and Endocrinology, University Hospitals of Morecambe Bay, said: “Diabetes is a chronic disease which currently affects 3.8 million people in the UK and is rising each year. It has a huge impact on the person’s day-to-day life, so treatment convenience is extremely important and must not be underestimated, as it can be crucial for helping patients to manage their condition.”

Dr Mike Baxter, Medical Therapy Area Expert, Diabetes said: “At Sanofi, we have been developing insulin treatments for diabetes for close to a century, so our commitment to the patient community is steadfast. We are delighted that DoubleStar is now available in the UK as it has been developed with patients in mind, to support them to reach their treatment goals.”

DoubleStar is a disposable pre-filled pen containing up to 900 units of insulin glargine1 It has the highest unit capacity of any basal insulin pen on the market, providing from 2-160 units of insulin in a single injection.

DoubleStar is recommended for appropriate adult patients with diabetes mellitus who require at least 20 units of basal insulin per day.

Toujeo (insulin glargine 300 units/mL) is a solution for injection that contains the active substance insulin glargine. It is long-acting human insulin analogue indicated to improve glycaemic control in adults with type 1 or type 2 diabetes. It is available in pre-filled SoloStar® and now DoubleStar pens.

Comments (0)

Register an account or login to comment